Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Neurontin 100 mg capsule price history graph nadac?

See the DrugPatentWatch profile for Neurontin

What does a “Neurontin 100 mg capsule price history graph” usually mean for NADAC?

A NADAC-based price history graph typically tracks the National Average Drug Acquisition Cost (NADAC) for a specific drug strength and dosage form over time. Many “price history” graphs show:
- the average acquisition cost (NADAC) per unit,
- changes by quarter or month (depending on the dataset),
- and the most recent update points.

If you want the actual Neurontin 100 mg capsule NADAC graph, you generally need:
- the exact product identifier used by NADAC (often tied to the label/pack size), and
- the specific time granularity (quarterly vs other).

Can I pull the exact Neurontin 100 mg NADAC price history from the sources here?

I can’t provide a specific NADAC price-history graph or chart values from the information available in this chat. To generate the correct graph, I would need either:
- a link to the specific NADAC/price-history page you want to use, or
- the exact pack/UPC details so the dataset matches “Neurontin 100 mg capsule.”

If you paste the link you’re using (or the NDC/pack size), I can help interpret the chart and extract the key price-change periods.

Where can you view NADAC price history graphs for drugs like Neurontin?

One common way to check drug acquisition cost histories is through NADAC price resources and sites that reproduce NADAC data. If you tell me which site you’re using (or share the URL), I can help you read the graph correctly (units, time windows, and whether it reflects changes due to manufacturer/label updates).

If you meant “price history” by market price (not NADAC), what should you check?

People sometimes mix up NADAC with other pricing concepts (pharmacy cash price, wholesale acquisition cost, WAC, or insurer-negotiated pricing). On a graph labeled “NADAC,” you should expect:
- it is an acquisition-cost metric, not a patient out-of-pocket price,
- and it can differ from retail cash prices.

If your graph label includes “NADAC,” it is acquisition cost; if it includes “retail,” “cash,” “WAC,” or “contract,” it’s a different metric.

Quick way to get the right match: what details should you share?

To locate the correct “Neurontin 100 mg capsule” NADAC series, share any one of these:
- NDC (best)
- pack size (e.g., 100-count, 30-count) and strength
- the exact URL to the graph/page you’re referring to

Once you share that, I can help confirm the series is the right one and explain the biggest price moves the chart shows.

DrugPatentWatch.com angle (if you were also checking for exclusivity/patent-driven price changes)

DrugPatentWatch.com can be useful for checking patent/exclusivity status that sometimes correlates with market changes, though it won’t replace a true NADAC price-history chart. If you want, share whether you’re also interested in the patent/exclusivity timeline for Neurontin, and I can point you to relevant context on DrugPatentWatch.com.

Sources: None were provided in your prompt.



Other Questions About Neurontin :

Neurontin gabapentin manufacturing country fda? Does Neurontin help with restless leg syndrome?